Myeloma Doctors Abroad — Page 2

Professor Deniz Gören brings world-class expertise to myeloma care, having refined her medical training at Harvard University Faculty of Medicine.

• Specialises in blood and marrow transplantation for complex haematological conditions
• Completed international transplant training with the European Society for Blood and Marrow Transplantation
• Member of the Turkish Academy of Blood Science specialising in lymphatic system disorders
• Expert in internal medicine and haematology at Memorial Şişli Hospital

The doctor graduated from Ankara University Medical School and completed residency training in internal medicine at Ankara GATA Medical School. Specializing in medical oncology and hematology, the doctor completed a clinical fellowship in the USA. A pioneer in Turkey, the doctor was part of the team that performed the first bone marrow transplantation in the country. The doctor has served as a visiting lecturer at prestigious institutions in London and Switzerland. Holding the European Medical Oncology Certificate, the doctor is a founding member of both The Turkish Society of Medical Oncology and the Turkish Oncology Group. The clinical focus includes breast, gastrointestinal, lung cancers, lymphomas, and myeloma.

Dr Litleaungdej graduated with honours from Naresuan University and holds a Thai Board certification in haematology. She practiced at Thammasat University Hospital, a major academic centre with a specialised haematology unit.

• Completed a dedicated haematology fellowship at Thammasat University
• Specialises in managing complex blood disorders including myeloma cases
• Co-authored research on clinical risk prediction for cancer-associated thrombosis
• Served as a pioneer haematologist at Hua Hin Hospital
• Member of the Pharmacy and Therapeutics Committee at Bangbuatong Hospital

Associate Professor Rafet Eren is a leading specialist in blood disorders at Valued Med Hub Hospitals, with deep expertise in managing complex myeloma cases.

• Specialises in multiple myeloma and plasma cell disorders
• Highly academic background with a PhD in clinical haematology
• Former head of haematology units at several major university teaching hospitals
• Researches improved diagnostic methods including bone marrow biopsy utility
• Manages supportive care for myeloma-related issues like anaemia and thrombocytopenia

Professor Ayhan Gulsan is a leading haematology specialist who founded and managed the Adult Stem Cell Transplant Unit at Gazi University. He completed elite fellowships at Duke University and the Fred Hutchinson Cancer Center in the USA.

• Specialises in autologous and allogeneic stem cell transplantation for myeloma patients
• Expert in post-transplant consolidation therapy using bortezomib to manage bone disease
• Researched monitoring free light chains to predict outcomes after stem cell transplants
• Former Head of Haematology at Gazi University, training the next generation of specialists
• Member of the European Society for Blood and Marrow Transplantation (EBMT)

Professor Leylagül Kaynar leads the Hematology and Bone Marrow Transplant Department at Medipol Mega University Hospital. She brings global expertise from her time as a research scholar at the Duke University Bone Marrow Transplant Center in the USA.

• Specialises in bone marrow transplants (BMT) to treat myeloma and other blood disorders
• Former Director of an Apheresis Unit – uses specialised equipment to collect healthy stem cells
• Served as Head of Hematology at the Bahrain Oncology Center
• Qualified Professor with multiple leadership roles at Erciyes University medical faculty

Professor Hasan Atilla Ozkan is the current President of the Turkish Therapeutic Apheresis Association and a highly decorated specialist in blood-related cancers.

• Performs autologous and allograft stem cell transplants – using bone marrow to reboot the immune system
• Holds EBMT certification for bone marrow transplantation – recognized by Europe's leading transplant authority
• Specialises in geriatric haematology – catering specifically to the needs of older patients with myeloma
• Expert in therapeutic apheresis – a process that filters blood to remove harmful proteins

Professor Mustafa Serkan Alemdar specialises in medical oncology with a deep focus on chemo-immunotherapy protocols at Medical Park Antalya.

• Trained at Akdeniz University – a leading Turkish centre for internal medicine and oncology
• Manages bone marrow cancers including myeloma through targeted drug therapies
• Expertise in systemic cancer treatments that use the immune system to fight tumours
• Clinical background includes senior roles at major research and training hospitals